Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:469251rdf:typepubmed:Citationlld:pubmed
pubmed-article:469251lifeskim:mentionsumls-concept:C0301896lld:lifeskim
pubmed-article:469251lifeskim:mentionsumls-concept:C0009511lld:lifeskim
pubmed-article:469251lifeskim:mentionsumls-concept:C0279023lld:lifeskim
pubmed-article:469251lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:469251pubmed:issue3lld:pubmed
pubmed-article:469251pubmed:dateCreated1979-10-26lld:pubmed
pubmed-article:469251pubmed:abstractTextAntibody-dependent cytolytic effector lymphocytes are known to possess, in part, receptors for activated C3. Employing a model system consisting of 51Cr-labeled chicken erythrocytes and purified human peripheral lymphocytes, we investigated the effect of target cell bound C3b on antibody-dependent cellular cytotoxicity (ADCC). At concentrations of anti-target cell antibody too low to cause effective ADCC, target cell bound C3b cooperated with antibody to produce marked target cell lysis. In the presence of a 1/6.25 X 10(6) dilution of anti-chicken erythrocyte rabbit IgG, cell lysis increased from 20% to 65% by the attachment of 18,000 C3b molecules per cell. C3b-dependent enhancement of ADCC was dose dependent. It was augmented by attachment of activated properdin (P) to the C3b-bearing target cells.lld:pubmed
pubmed-article:469251pubmed:languageenglld:pubmed
pubmed-article:469251pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:469251pubmed:citationSubsetAIMlld:pubmed
pubmed-article:469251pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:469251pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:469251pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:469251pubmed:statusMEDLINElld:pubmed
pubmed-article:469251pubmed:monthSeplld:pubmed
pubmed-article:469251pubmed:issn0022-1767lld:pubmed
pubmed-article:469251pubmed:authorpubmed-author:Müller-Eberha...lld:pubmed
pubmed-article:469251pubmed:authorpubmed-author:MedicusR GRGlld:pubmed
pubmed-article:469251pubmed:authorpubmed-author:GhebrehiwetBBlld:pubmed
pubmed-article:469251pubmed:issnTypePrintlld:pubmed
pubmed-article:469251pubmed:volume123lld:pubmed
pubmed-article:469251pubmed:ownerNLMlld:pubmed
pubmed-article:469251pubmed:authorsCompleteYlld:pubmed
pubmed-article:469251pubmed:pagination1285-8lld:pubmed
pubmed-article:469251pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:469251pubmed:meshHeadingpubmed-meshheading:469251-H...lld:pubmed
pubmed-article:469251pubmed:meshHeadingpubmed-meshheading:469251-A...lld:pubmed
pubmed-article:469251pubmed:meshHeadingpubmed-meshheading:469251-A...lld:pubmed
pubmed-article:469251pubmed:meshHeadingpubmed-meshheading:469251-R...lld:pubmed
pubmed-article:469251pubmed:meshHeadingpubmed-meshheading:469251-P...lld:pubmed
pubmed-article:469251pubmed:meshHeadingpubmed-meshheading:469251-C...lld:pubmed
pubmed-article:469251pubmed:meshHeadingpubmed-meshheading:469251-D...lld:pubmed
pubmed-article:469251pubmed:meshHeadingpubmed-meshheading:469251-C...lld:pubmed
pubmed-article:469251pubmed:meshHeadingpubmed-meshheading:469251-A...lld:pubmed
pubmed-article:469251pubmed:year1979lld:pubmed
pubmed-article:469251pubmed:articleTitlePotentiation of antiboty-dependent cell-mediated cytotoxicity by target cell-bound C3b.lld:pubmed
pubmed-article:469251pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:469251pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:469251lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:469251lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:469251lld:pubmed